Epithelial L4

COVID-19 and Epithelial Sodium Channels (ENaC)

Overview of COVID-19 Virus Structure

  • The COVID-19 virus is characterized by several structural components:

    • Spike Proteins: Comprising S1 and S2 subunits, these proteins are critical for viral entry into host cells.

    • Nucleocapsid (N): A protein that encases the viral RNA.

    • Membrane (M) Protein: Integral to the virus structure.

    • Envelope (E) Protein: A component surrounding the viral membrane.

    • The virus possesses single-stranded RNA (SSRNA) that is approximately 30 kb in length and is categorized as positive-sense.

Study Aim and Objectives

  • The primary aim of the study is to evaluate the efficacy of dexamethasone treatment in patients with COVID-19 and to analyze gender differences observed in COVID-19 cases. The objectives are as follows:

    • Identify key risk factors associated with COVID-19 infection.

    • Assess the impact of dexamethasone on the airway and rationalize its benefits as a treatment option for COVID-19.

    • Discuss potential biological mechanisms by which oestrogen may contribute to sex differences in COVID-19 outcomes.

Pulmonary Oedema in COVID-19 Patients

Severity of Acute Respiratory Distress Syndrome (ARDS)

  • COVID-19 patients exhibit a higher incidence of pulmonary oedema when compared to other patients suffering from ARDS. This is observed in critical care settings where patients are often on ventilators (Rasch et al., Sci Reports, 2021, 11: 11524).

  • The Extra Vascular Lung Water Index (EVLWI) is an important diagnostic metric to understand the volume of oedema.

Clinical Associations

  • Elevated EVLWI in COVID-19 patients correlates with prolonged ICU stays and increased mortality rates (Rasch et al., Sci Reports, 2021, 11: 11524).

    • Survival Analysis:

      • Survived: EVLWI = 23.2 ± 6.7

      • Died: EVLWI = 30.3 ± 6

Causes of Pulmonary Oedema Related to SARS-CoV-2

  • The development of pulmonary oedema due to SARS-CoV-2 infection is attributed to multiple factors:

    • Damage to alveolar and vascular epithelial cells (FUNCTION, 2020, 1(2): Gentzsch & Rossier).

    • Increased vascular permeability leading to fluid leakage into the alveolar spaces.

    • Decreased alveolar fluid clearance (AFC), affecting the normal fluid homeostasis in the lungs.

    • Note the importance of the upper airway and airway surface liquid (ASL) in maintaining lung health and function.

Dexamethasone in COVID-19 Treatment

Introduction to Dexamethasone

  • Dexamethasone is a synthetic glucocorticoid developed in 1957, widely used to treat inflammatory diseases, especially conditions affecting the airways, such as asthma.

  • It is anticipated that dexamethasone targets multiple pathways and mechanisms to exhibit its beneficial effects in COVID-19.

Impact of Dexamethasone on Hospitalization

  • A pivotal study known as the RECOVERY TRIAL highlights the effects of dexamethasone on hospitalization duration.

    • Patients treated with dexamethasone had a median hospital stay of 12 days compared to 13 days for those not receiving dexamethasone (NEJM, 2021, 384: 693-704).

Mechanisms of Action

  • Dexamethasone plays a crucial role in the inhibition of cytokine storms, which are characterized by excessive inflammation following viral infection. Activation of dexamethasone counters these inflammatory responses (Andreakos et al., Allergy, 2021, 76: 626-628).

Interaction of Dexamethasone with ENaC

Effect on TNF Inhibition of ENaC

  • Tumor necrosis factor (TNF) has been found to inhibit the epithelial sodium channel (ENaC).

  • Dexamethasone has been shown to reverse TNF's inhibitory effects on ENaC in alveolar cells, indicated by changes in mRNA levels (Am J Physiol Lung Cell Mol Physiol 291: L1220–L1231, 2006).

Measurement of Isc in Response to Dexamethasone

  • Experimental results demonstrate reversal of TNF inhibition of ENaC under different conditions by measuring Isc, or short-circuit current, providing insights into fluid regulation in response to treatment. Detailed research findings can be referenced from the aforementioned publication.

Effects on Chloride Secretion and ASL Dynamics

  • Dexamethasone treatment results in the inhibition of potassium (K+) channels, leading to a decreased driving force for chloride (Cl-) secretion.

    • This mechanism could subsequently result in a reduction in ASL within the airways, impacting fluid absorption in severe COVID-19 ARDS cases.

  • The therapeutic benefits of dexamethasone include:

    • Encouragement of fluid absorption through ENaC, especially in upper airway and alveolar regions.

    • Reduction of ASL and alveolar fluid, thereby mitigating pulmonary oedema.

    • Antiinflammatory properties beneficial for managing patient outcomes.

Potential Side Effects

  • While dexamethasone has significant therapeutic effects, prolonged use may lead to various side effects, including:

    • Hypokalaemia (low potassium levels)

    • Hypotension (low blood pressure)

    • Cardiac arrhythmias

    • Renal failure

    • Weight, bone, and vision loss.

    • Some studies indicate that higher doses could negatively affect mortality rates.

Biological Sex Differences in COVID-19

Global Data Analysis

  • Considering the data from the Sex and Gender and COVID-19 Project shows a significant disparity in COVID-19 outcomes based on biological sex:

    • Testing results: 8 tests for males vs. 10 cases for males; hospitalizations: 12 male cases, 17 ICU admissions, and 13 deaths.

Mortality Rates by Age and Sex

  • Age and biological sex significantly influence mortality rates, as depicted in graphs illustrating deaths per 100,000 individuals across different age groups.

Biological Sex and Other Lung Conditions

  • Research shows that biological sex influences outcomes in other lung conditions, such as:

    • Cystic Fibrosis (CF) where females typically have poorer outcomes.

    • Asthma, where females fare better pre-puberty, but males perform better post-puberty.

    • The role of oestrogen (17 beta estradiol) is vital, as it has multiple effects: it enhances immune responses, reduces inflammation, and impacts lung airway surface liquid dynamics.

Implications of Oestrogen on COVID-19 Outcomes

  • Oestrogen appears to lower ASL levels in females during CF, leading to poorer outcomes. Conversely, its presence in COVID-19 may contribute to better outcomes by mitigating elevated ASL levels.

    • Importantly, oestrogen reduces pro-inflammatory cytokine levels and ACE2 mRNA expression, which has implications for male biases in COVID-19 severity due to higher ACE2 levels in biological males.

Conclusion

  • The study has reviewed key risk factors associated with COVID-19, evaluated the role of dexamethasone as a treatment option, and examined how oestrogen influences outcomes differently across genders. Notable reference:

    • Newson et al., "Sensitive to Infection but Strong in Defense - Female Sex and the Power of Oestradiol in the COVID-19 Pandemic," Frontiers in Global Women's Health (2021). DOI: 10.3389/fgwh.2021.651752.